Société Tunisienne des Maladies Respiratoires et d'Allergologie STMRA - M-A: Prophylaxis against Covid-19: 1 – no benefit from Hydroxychloroquine; 2 – as studies on ivermectin so far have been small, it remains very uncertain whether ivermectin reduces SARS-CoV-2 infection

Sté Tunisienne des Maladies Respiratoires et d'Allergologie

Cercle des Bureaux - Appartement B 5-3 . 1082 Centre urbain Nord Tunis

M-A: Prophylaxis against Covid-19: 1 – no benefit from Hydroxychloroquine; 2 – as studies on ivermectin so far have been small, it remains very uncertain whether ivermectin reduces SARS-CoV-2 infection

M-A: Prophylaxis against Covid-19: 1 – no benefit from Hydroxychloroquine; 2 – as studies on ivermectin so far have been small, it remains very uncertain whether ivermectin reduces SARS-CoV-2 infection

Zouhair Souissi

Bibliographie

27 avril 2021

Prophylaxis against covid-19: living systematic review and network meta-analysis – The BMJ

The post M-A: Prophylaxis against Covid-19: 1 – no benefit from Hydroxychloroquine; 2 – as studies on ivermectin so far have been small, it remains very uncertain whether ivermectin reduces SARS-CoV-2 infection appeared first on Links Medicus.

Lu 698 fois

Taille de police Réduire la taille de la police Augmenter la taille de police

Évaluer cet élément

1
2
3
4
5

(0 Votes)

Plus dans cette catégorie : « ACP Guideline: Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emergency Department or Inpatient Settings Study in nursing homes shows rapid antigen testing could be a useful tool to identify contagious people at risk for transmitting SARS-CoV-2 »

About Author

Zouhair Souissi

Dernier de Zouhair Souissi

Recherche